Compass Diversified (CODI) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
17 Jan, 2026Executive summary
Achieved double-digit revenue growth in Q3 2024, with net sales up 11.8% to $582.6M, driven by strong branded consumer performance, including Lugano, BOA, and The Honey Pot Co., and stabilization in industrial businesses.
Adjusted EBITDA reached a record $114M in Q3 2024, up 28% year-over-year, and adjusted earnings rose 65% to $48.7M.
Net income from continuing operations was $31.5M in Q3 2024, reversing a prior year loss.
Raised full-year 2024 guidance based on strong performance and positive business momentum.
Awarded Inc. Magazine's Founder-Friendly Investor Award, highlighting collaborative approach with subsidiaries.
Financial highlights
Q3 2024 consolidated net sales were $582.6M, up 11.8% year-over-year; pro forma sales grew 6.6%.
Q3 2024 gross profit margin improved to 47.1% from 43.2% in Q3 2023.
Q3 2024 net income was $31.5M, compared to a net loss of $3.8M in Q3 2023.
Adjusted EBITDA for Q3 2024 was $114M, a 28% increase year-over-year.
Ended Q3 with $71.9M in cash and over $480M available on revolver; total leverage ratio at 3.68x.
Outlook and guidance
Raised full-year 2024 guidance: consolidated pro forma subsidiary adjusted EBITDA expected between $510M–$525M, including The Honey Pot Co.
Branded consumer vertical adjusted EBITDA expected at $390M–$400M; industrial vertical at $120M–$125M.
Consolidated adjusted EBITDA expected between $420M–$435M; adjusted earnings between $155M–$165M.
Guidance includes The Honey Pot Company for the full year 2024 and excludes impact of future acquisitions or divestitures.
Latest events from Compass Diversified
- Strong Q2 with double-digit adjusted EBITDA growth, debt reduction, and robust branded consumer gains.CODI
Q2 2026 - All directors re-elected and major proposals approved by strong shareholder majorities.CODI
AGM 2026 - Q1 2026 delivered strong consumer growth, Sterno sale, improved leverage, and a $20.5M impairment.CODI
Q1 2026 - Core subsidiaries delivered revenue and EBITDA growth in 2025 despite Lugano-related disruption.CODI
Q4 2025 - $380M acquisition of a high-growth feminine care brand closing February 2024.CODI
Investor update - Q3 sales up 3.5%, but net loss widened and liquidity risks remain amid ongoing uncertainties.CODI
Q3 2025 - Branded consumer strength drove 11% sales growth and 27% higher Adjusted EBITDA in Q2 2024.CODI
Q2 2024 - High-growth, innovative portfolio and disciplined strategy target $1B+ EBITDA by 2028.CODI
Investor Day 2025 - 2024 saw strong sales and EBITDA growth, with 2025 guidance projecting further gains.CODI
Q4 2024